References
Abrams J. The brief saga of transdermal nitroglycerin. discs: Paradise Lost? American Journal of Cardiology 54: 220–224, 1984
Abrams J. Transdermal nitroglycerin and nitrate tolerance. Annals of Internal Medicine 104: 424–426, 1986
Abrams J. A reappraisal of nitrate therapy. Clinical Cardiology 259: 396–401, 1988
Bridgman KM, Carr M, Tattersall AB. Post-marketing surveillance of the transderm-nitro patch in general practice. Journal of International Medical Research 12: 40–45, 1984
Colditz GA, Halvorsen KT, Goldhaber SZ. Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis. American Heart Journal 116: 174–180, 1988
Connor CS, Gelman CJR. Transdermal nitroglycerin: a reevaluation. Drug Intelligence and Clinical Pharmacy 18: 889–890, 1984
Cowan JC, Bourke JP, Reids DS, et al. Prevention of tolerance to nitroglycerin patches by overnight removal. American Journal of Cardiology 60: 271–275, 1987
Crean PA, Ribeiro P, Crea F, et al. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, crossover trial. American Heart Journal 6: 1494–1500, 1984
Curry SH. Transdermal nitroglycerin patches. Clinical Pharmacy 4: 453–454, 1985
Dahlstrom CG, Rasmussen K, Bagger JP, et al. Transdermal nitroglycerin (Transiderm-Nitro) in the treatment of unstable angina pectoris. Danish Medical Bulletin 33: 265–267, 1986
Demots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. Journal of the American College of Cardiology 13: 789–793, 1989
Desilvio A, Barlattani MP. How best to use nitrates. British Medical Journal 295: 1163–1164, 1987
Dickstein K, Knutsen H. A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system vs placebo. European Heart Journal 6: 50–56, 1985
Dogar H, Güzelsoy D, Gultekin N, Gurses N, Demiroglo C. Active and sustained antianginal effects of nitroglycerin patches: objective evaluation with training effect eliminated exercise performance index. American Journal of Cardiology 61: 39E–43E, 1988
Ferratini M, Pirelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise induced angina: a comparison with a continuous schedule. European Heart Journal 10: 998–1002, 1989
Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 2: 4–7, 1988
Garnier H, Johnson LC. Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (Nitroderm TTS). Schweiz Rundsch Med Prax 71: 511–516, 1982
Georgopoulos AJ, Markis A, Georgiadis H. Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris. European Journal of Clinical Pharmacology 22: 481–485, 1982
Greco R, D’Alterio D, Schiatterella M, Boccia A, Greco L, et al. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris. American Journal of Cardiology 61: 41E–51E, 1988
Heepe W. An acute double-blind placebo-controlled study of transdermal glyceryl trinitrate with 12 months’ follow up in patients with stable angina pectoris. Journal of International Medical Research 15: 198–204, 1987
James MA, Walker PR, Papouchado M, Wilkinson PR. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris. British Heart Journal 53: 631–635, 1985
Kapoor AS, Narinder SD, Reynolds RD. Sustained effects of transdermal nitroglycerin in patients with angina pectoris. Clinical Therapeutics 7: 674–679, 1985
Letzel.H, Johnson LC. Advances in nitrate therapy for ischaemic heart disease: results of a multicentre study with Transiderm Nitro. Zeitschrift für Allgemeinmedizin 59: 1022–1027, 1983
Letzel H, Johnson LC. Treatment of angina pectoris with Nitroderm TTS: results of a multicentre field study in 37, 596 patients. Medizinische Welt 35: 326–332, 1984
Luke R, Sharpe N, Coxon R. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. Journal of the American College of Cardiology 10: 642–646, 1987
Midtbo K. A comparative study of transdermal nitroglycerin versus placebo in the treatment of stable angina pectoris. In Bussmann W & Zanchetti A (Eds) Transdermal nitroglycerin therapy, pp. 35–41, Hans Huber, 1985
Mufson LH, Wenger NK. Transdermal nitroglycerin discs: are they effective therapy? Quality of Life and Cardiovascular Care 2: 319–322, 1986
Muiesan G, Agabiti-Rossei E, Muiesan L, et al. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration. American Heart Journal 112: 233–238, 1986
Nabel EG, Barry J, Rocco MB, et al. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. American Journal of Cardiology 63: 663–669, 1989
Parker JO. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy. American Journal of Cardiology 54: 8–13, 1984
Parker JO. Efficacy of nitroglycerin patches: fact or fancy. Annals of Internal Medicine 102: 548–550, 1985
Parker JO. Nitrate therapy in stable angina pectoris. New England Journal of Medicine 316: 1635–1640, 1987
Parker JO. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. Journal of the American College of Cardiology 13: 794–795, 1989
Parker JO, Fung HL. Transdermal nitroglycerin in angina pectoris. American Journal of Cardiology 54: 471–476, 1984
Pirelli CS, Ferratini M, Gasparini G, et al. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris. European Heart Journal 9: 105–111, 1988
Reichek N, Priest C, Zimrin D, et al. Antianginal effects of nitroglycerin patches. American Journal of Cardiology 54: 1–7, 1984
Rezakovic DE. Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients. American Journal of Cardiology 61: 59E–69E, 1988
Rezakovic DE, Pavicic L, Majacic M. A randomised placebo controlled, double-blind crossover trial of transdermal nitroglycerin in stable angina pectoris. European Heart Journal 9: 73–81, 1988
Scardi S, Pandullo C, Pivotti F, et al. Individual responses to transdermal nitrates after chronic administration in angina pectoris. International Journal of Cardiology 21: 21–32, 1988
Scardi S, Pivotti F, Fonda F, et al. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris. American Heart Journal 110: 546–551, 1985
Schaer DH, Buff LA, Katz RJ. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10 hour nitrate-free interval. American Journal of Cardiology 61: 46–50, 1988
Scheidt S. Update on transdermal nitroglycerin: an overview. American Journal of Cardiology 56: 50–71, 1985
Sullivan M, Savvides M, Abouantoun S, et al. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris. Journal of the American College of Cardiology 5: 1220–1223, 1985
Terland O, Eidsaunet W. A double-blind multicenter crossover general practice study of glyceryl trinitrate delivered by a transdermal therapeutic system in stable angina pectoris. Current Therapeutic Research 39: 214–222, 1986
Thadani U, Hamilton SF, Olson E. Transdermal nitroglycerin patches in angina pectoris. Annals of Internal Medicine 105: 485–492, 1986
Thompson R. Influence of transdermal nitrates on exercise capacity in patients with stable angina. Angiology 37(6): 448–453, 1986
Waters DD, Juneau M, Gossard D, Choquette G, Brien M. Limited usefulness of intermittent nitroglycerin patches in stable angina. Journal of the American College of Cardiology 13: 421–425, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, A. Transdermal Nitroglycerin. Drugs & Aging 1, 6–16 (1991). https://doi.org/10.2165/00002512-199101010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101010-00003